Leptospirosis in Emergency Medicine Clinical Presentation

  • Author: Judith Green-McKenzie, MD, MPH; Chief Editor: Rick Kulkarni, MD   more...
 
Updated: Jan 13, 2010
 

History

Leptospirosis infection has protean manifestations. As a result, it is frequently misdiagnosed. Approximately 15-40% of exposed patients who do not become ill have serologic evidence of past infection. This statistic includes 15% of abattoir workers, packinghouse workers, and veterinarians.

  • The incubation period is usually 7-12 days, with a range of 2-20 days.
  • Approximately 90% of patients manifest a mild anicteric form of the disease, and approximately 5-10% have the severe form with jaundice, otherwise known as Weil disease.
  • The natural course of leptospirosis falls into 2 distinct phases: septicemic and immune. During a brief period of 1-3 days between the 2 phases, the patient shows some improvement.
    • First stage
      • This stage is called the septicemic or leptospiremic stage because the organism may be isolated from blood cultures, cerebrospinal fluid (CSF), and most tissues.
      • During this stage, which lasts about 4-7 days, the patient develops a nonspecific flulike illness of varying severity.
      • It is characterized by fever, chills, weakness, and myalgias, primarily affecting the calves, back, and abdomen.
      • Other symptoms include sore throat, cough, chest pain, hemoptysis, rash, frontal headache, photophobia, mental confusion, and other symptoms of meningitis.
      • Because of the abrupt nature of the onset, the patient can often tell exactly when the symptoms started.
      • During the 1-3 day period of improvement that follows the first stage, the temperature curve falls and the patient may become afebrile and relatively asymptomatic. The fever then recurs, indicating the onset of the second stage when clinical or subclinical meningitis appears.
    • Second stage
      • This stage is called the immune or leptospiruric stage because circulating antibodies may be detected or the organism may be isolated from urine; it may not be recoverable from blood or CSF.
      • This stage occurs as a consequence of the body's immunologic response to infection and lasts 0-30 days or more.
      • Disease referable to specific organs is seen. These organs include the meninges, liver, eyes, and kidney. An example of leptospirosis affecting the liver is seen in the image below. Silver stain, liver, fatal human leptospirosis. (TSilver stain, liver, fatal human leptospirosis. (This image is in the public domain and thus free of any copyright restrictions. Courtesy of the Centers for Disease Control/Dr. Martin Hicklin.)
      • Nonspecific symptoms, such as fever and myalgia, may be less severe than in the first stage and last a few days to a few weeks.
      • Many patients (77%) experience headache that is intense and poorly controlled by analgesics; this often heralds the onset of meningitis.
      • Aseptic meningitis is the most important clinical syndrome observed in the immune anicteric stage. Meningeal symptoms develop in 50% of patients. Cranial nerve palsies, encephalitis, and changes in consciousness are less common. Mild delirium may also be seen. Symptoms may be nonspecific, and a viral etiology may be suspected. Meningitis usually lasts a few days but occasionally lasts 1-2 weeks. Death is extremely rare in the anicteric cases.
      • Leptospires may be isolated from the blood for 24-48 hours after jaundice appears. Abdominal pain with diarrhea or constipation (30%), hepatosplenomegaly, nausea, vomiting, and anorexia are also seen.
      • Uveitis (2-10%) can develop early or late in the disease and has been reported to occur as late as one year after initial illness. Iridocyclitis and chorioretinitis are other late complications that may persist for years. These symptoms first manifest 3 weeks to 1 month after exposure. Subconjunctival hemorrhage is the most common ocular complication of leptospirosis, occurring in as many as 92% of patients. Leptospires may be present in the aqueous humor.
      • Renal symptoms (eg, azotemia, pyuria, hematuria, proteinuria, and oliguria are seen in 50% of patients with leptospirosis. Leptospires may be present in the kidney.
      • Pulmonary manifestations occur in 20-70% of patients, usually have a benign course, and may occur in both the icteric and anicteric forms of the disease. However, pulmonary involvement is the main cause of death due to leptospirosis in some countries, usually as a result of pulmonary hemorrhage or acute respiratory distress syndrome. Indeed, the severe pulmonary form of leptospirosis (SPFL) is considered to be one of the major causes of death in patients with severe leptospirosis.
      • Adenopathy, rashes, and muscular pain are also seen.
  • Clinical syndromes are not specific to the serotype, although some manifestations may be seen more commonly with some serotypes.
  • Often, the serovar helps determine some of the more characteristic clinical manifestations, but any leptospiral serovar can lead to the signs and symptoms seen with this disease. For example, jaundice is seen in 83% of patients with L icterohaemorrhagiae infection and in 30% of patients infected with L pomona. A characteristic pretibial erythematous rash is seen in patients with L autumnalis infection. Similarly, GI symptoms predominate in patients infected with L grippotyphosa. Aseptic meningitis commonly occurs in those infected with L pomona or L canicola.
  • Weil syndrome is the severe form of leptospirosis and primarily manifests as profound jaundice, renal dysfunction, hepatic necrosis, pulmonary dysfunction, and hemorrhagic diathesis.
    • It occurs at the end of the first stage and peaks in the second stage; however, the patient's condition can deteriorate suddenly at any time. Often, the transition between the stages is obscured.
    • Fever may be marked during the second stage.
    • Criteria to determine the development of Weil disease are not well defined.
    • Pulmonary manifestations include cough, dyspnea, chest pain, bloodstained sputum, hemoptysis, and respiratory failure.
    • Vascular and renal dysfunction accompanied by jaundice develop 4-9 days after onset of disease, and jaundice may persist for weeks.
    • Patients with severe jaundice are more likely to develop renal failure, hemorrhage, and cardiovascular collapse. Hepatomegaly and tenderness in the right upper quadrant may be present.
    • Oliguric or anuric acute tubular necrosis may occur during the second week due to hypovolemia and decreased renal perfusion.
    • Multiorgan failure, rhabdomyolysis, adult respiratory distress syndrome, hemolysis, splenomegaly, congestive heart failure, myocarditis, and pericarditis may also occur.
    • Weil syndrome carries a mortality rate of 5-10%. The most severe cases of Weil syndrome, with hepatorenal involvement and jaundice, have a case-fatality rate of 20-40%. The mortality rate is usually higher for older patients.
  • Leptospirosis may present with a macular or maculopapular rash, abdominal pain that resembles acute appendicitis, or generalized enlargement of lymphoid glands, resembling infectious mononucleosis. It may also present as aseptic meningitis, encephalitis, or fever of unknown origin.
  • Leptospirosis should be considered when a patient has a flulike disease with aseptic meningitis or disproportionately severe myalgia.
Next

Physical

  • First stage: Common physical findings include fever; subconjunctival suffusion; pharyngeal injection; splenomegaly; hepatomegaly; mild jaundice; muscle tenderness; lymphadenopathy; and a macular, maculopapular, erythematous, urticarial, or hemorrhagic rash.
  • Second stage: Physical findings depend on organ involvement.
    • General - Adenopathy, rash, fever, bleeding, signs of hypovolemia/cardiogenic shock
    • Icteric - Jaundice, hepatomegaly, abdominal tenderness, signs of coagulopathy
    • Pulmonary - Cough, hemoptysis, dyspnea, respiratory distress
    • Neurologic - Cranial nerve palsies, confusion, changes in consciousness, delirium, other signs of meningitis
    • Ocular - Subconjunctival hemorrhage, uveitis, signs of iridocyclitis or chorioretinitis
    • Hematologic - Bleeding, petechiae, purpura, ecchymosis, splenomegaly, abdominal tenderness
    • Cardiac - Signs of congestive heart failure, pericarditis
Previous
 
 
Contributor Information and Disclosures
Author

Judith Green-McKenzie, MD, MPH  Associate Professor, Director of Clinical Practice, Occupational Medicine Residency Director, University of Pennsylvania School of Medicine

Judith Green-McKenzie, MD, MPH is a member of the following medical societies: American College of Occupational and Environmental Medicine, American College of Physicians, American College of Preventive Medicine, National Medical Association, and Society of General Internal Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

William H Shoff, MD, DTM&H  Director, PENN Travel Medicine, Associate Professor, Department of Emergency Medicine, Hospital of the University of Pennsylvania

William H Shoff, MD, DTM&H is a member of the following medical societies: American College of Physicians, American Society of Tropical Medicine and Hygiene, International Society of Travel Medicine, Society for Academic Emergency Medicine, and Wilderness Medical Society

Disclosure: Glaxo Smith Kline None None; Glaxo Smith Kline Honoraria Speaking and teaching

Specialty Editor Board

Edmond A Hooker II, MD, DrPH, FAAEM  Assistant Professor, Department of Emergency Medicine, University of Cincinnati College of Medicine

Edmond A Hooker II, MD, DrPH, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American Public Health Association, Society for Academic Emergency Medicine, and Southern Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Jeter (Jay) Pritchard Taylor III, MD  Compliance Officer, Attending Physician, Emergency Medicine Residency, Department of Emergency Medicine, Palmetto Health Richland, University of South Carolina School of Medicine; Medical Director, Department of Emergency Medicine, Palmetto Health Baptist

Jeter (Jay) Pritchard Taylor III, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

References
  1. Palaniappan RU, Ramanujam S, Chang YF. Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis. Jun 2007;20(3):284-92. [Medline].

  2. Inada R, Ido Y, et al. Etiology, mode of infection and specific therapy of Weil's disease. J Exp Med. 1916;23:377-402.

  3. CDC. From the Centers for Disease Control and Prevention. Update: outbreak of acute febrile illness among athletes participating in Eco-Challenge-Sabah 2000--Borneo, Malaysia, 2000. JAMA. Feb 14 2001;285(6):728-30. [Medline].

  4. CDC. Update: leptospirosis and unexplained acute febrile illness among athletes participating in triathlons--Illinois and Wisconsin, 1998. MMWR Morb Mortal Wkly Rep. Aug 21 1998;47(32):673-6. [Medline].

  5. CDC. Outbreak of leptospirosis among white-water rafters - Costa Rica occupational infections. MMWR. 1997;46(25):77-578. [Medline].

  6. CDC. Outbreak of acute febrile illness and pulmonary hemorrhage--Nicaragua, 1995. JAMA. Dec 6 1995;274(21):1668. [Medline].

  7. Gaynor K, Katz AR, Park SY, Nakata M, Clark TA, Effler PV. Leptospirosis on Oahu: an outbreak associated with flooding of a university campus. Am J Trop Med Hyg. May 2007;76(5):882-5. [Medline].

  8. Cacciapuoti B, Ciceroni L, Maffei C. A waterborne outbreak of leptospirosis. Am J Epidemiol. Sep 1987;126(3):535-45. [Medline].

  9. Vasconcellos FA, Coutinho ML, da Silva EF, et al. Testing different antigen capture ELISA formats for detection of Leptospira spp. in human blood serum. Trans R Soc Trop Med Hyg. Nov 24 2009;[Medline].

  10. [Guideline] Guidugli F, Castro AA, Atallah AN. Antibiotics for preventing leptospirosis. Cochrane Database Syst Rev. 2000;CD001305. [Medline].

  11. Aston JM, Broom JC. Leptospirosis in Man and Animals. Edinburgh and London, England: Livingstone; 1958.

  12. Bajani MD, Ashford DA, Bragg SL, et al. Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol. Feb 2003;41(2):803-9. [Medline].

  13. Carvalho CR, Bethlem EP. Pulmonary complications of leptospirosis. Clin Chest Med. Jun 2002;23(2):469-78. [Medline].

  14. CDC. Brief report: Leptospirosis after flooding of a university campus--Hawaii, 2004. MMWR Morb Mortal Wkly Rep. Feb 10 2006;55(5):125-7. [Medline].

  15. Chu KM, Rathinam R, Namperumalsamy P. Identification of Leptospira species in the pathogenesis of uveitis and determination of clinical ocular characteristics in south India. J Infect Dis. May 1998;177(5):1314-21. [Medline].

  16. Cohen R, LaDou J, eds. Occupational Infections. In: Occupational Environmental Medicine. Connecticut: Appleton & Lange; 1997.

  17. Cole DJ, Hill VR, Humenik FJ. Health, safety, and environmental concerns of farm animal waste. Occup Med. Apr-Jun 1999;14(2):423-48. [Medline].

  18. Corwin A, Ryan A, Bloys W. A waterborne outbreak of leptospirosis among United States military personnel in Okinawa, Japan. Int J Epidemiol. Sep 1990;19(3):743-8. [Medline].

  19. De Serres G, Levesque B, Higgins R. Need for vaccination of sewer workers against leptospirosis and hepatitis A. Occup Environ Med. Aug 1995;52(8):505-7. [Medline].

  20. Dolhnikoff M, Mauad T, Bethlem EP, Carvalho CR. Leptospiral pneumonias. Curr Opin Pulm Med. May 2007;13(3):230-5. [Medline].

  21. Edwards GA, Domm BM. Human leptospirosis. Medicine (Baltimore). Feb 1960;39:117-56. [Medline].

  22. Farrar WE, Mandel GL, Bennett JE, Dolin R, eds. Leptospira species (leptospirosis). In: Principles and Practice of Infectious Diseases. New York, NY: Churchill Livingstone; 1995:2137-41.

  23. Feigin RD, Anderson DC. Human leptospirosis. CRC Crit Rev Clin Lab Sci. Mar 1975;5(4):413-67. [Medline].

  24. Feigin RD, Lobes LA Jr, Anderson D. Human leptospirosis from immunized dogs. Ann Intern Med. Dec 1973;79(6):777-85. [Medline].

  25. Fonseca C, Teixeira M, Romero E. Leptospira DNA detection for the diagnosis of human leptospirosis. J Infect Dis. 2006;52:15-22.

  26. Freedman DO, Woodall J. Emerging infectious diseases and risk to the traveler. Med Clin North Am. Jul 1999;83(4):865-83, v. [Medline].

  27. Griffith ME, Hospenthal DR, Murray CK. Antimicrobial therapy of leptospirosis. Curr Opin Infect Dis. Dec 2006;19(6):533-7. [Medline].

  28. Im JG, Yeon KM, Han MC, et al. Leptospirosis of the lung: radiographic findings in 58 patients. AJR Am J Roentgenol. May 1989;152(5):955-9. [Medline].

  29. Kaufman AF, Wenger JD, Last JM, Wallace RB, eds. Leptospirosis. In: Maxcy-Rosenau-Last Public Health and Preventive Medicine. 13th ed. Norwalk, CT: 1992:264-5.

  30. Lomar AV, Diament D, Torres JR. Leptospirosis in Latin America. Infect Dis Clin North Am. Mar 2000;14(1):23-39, vii-viii. [Medline].

  31. Manzin A, Solforosi L, Clementi M. Dynamics of viral quasispecies in hepatitis C virus infection. Res Virol. Mar-Apr 1997;148(2):171-6. [Medline].

  32. Mulla S, Chakraborty T, Patel M, et al. Diagnosis of leptospirosis and comparison of ELISA and MAT techniques. Indian J Pathol Microbiol. Jul 2006;49(3):468-70. [Medline].

  33. Ooteman MC, Vago AR, Koury MC. Evaluation of MAT, IgM ELISA and PCR methods for the diagnosis of human leptospirosis. J Microbiol Methods. May 2006;65(2):247-57. [Medline].

  34. Pellizzer P, Todescato A, Benedetti P, Colussi P, Conz P, Cinco M. Leptospirosis following a flood in the Veneto area, North-east Italy. Ann Ig. Sep-Oct 2006;18(5):453-6. [Medline].

  35. Shaked Y, Shpilberg O, Samra D. Leptospirosis in pregnancy and its effect on the fetus: case report and review. Clin Infect Dis. Aug 1993;17(2):241-3. [Medline].

  36. Sitprija V, Losuwanrak K, Kanjanabuch T. Leptospiral nephropathy. Semin Nephrol. Jan 2003;23(1):42-8. [Medline].

  37. Skilbeck NW, Miller GT, ALIA. A serological survey of leptospirosis in Gippsland dairy farmers. Med J Aust. May 26 1986;144(11):565-7. [Medline].

  38. Speelman P, Fauci AS, Brainwald E, eds. Leptospirosis. In: Harrison's Principles of Internal Medicine. 14th ed. 1998:756.

  39. Takafuji ET, Kirkpatrick JW, Miller RN, et al. Agricultural Occupational Medicine: An Efficacy Trial of Doxycycline Chemoprophylaxis against Leptospirosis. In: Occupational Medicine. St Louis, MO: Mosby; 1984:310, 497-500, 894-5.

  40. Tappero J, Ashford D, Perkins B. Leptospirosis. In: Principles and Practice of Infectious Disease. 5th ed. New York, NY: Churchill Livingstone; 1998.

  41. Vinetz JM, Glass GE, Flexner CE. Sporadic urban leptospirosis. Ann Intern Med. Nov 15 1996;125(10):794-8. [Medline].

  42. Yang CW, Wu MS, Pan MJ. Leptospirosis renal disease. Nephrol Dial Transplant. 2001;16 Suppl 5:73-7. [Medline].

Previous
Next
 
A scanning electron micrograph depicting Leptospira atop a 0.1-µm polycarbonate filter. (This image is in the public domain and thus free of any copyright restrictions. Courtesy of the Centers for Disease Control/Rob Weyant.)
Darkfield microscopy of leptospiral microscopic agglutination test. (This image is in the public domain and thus free of any copyright restrictions. Courtesy of the Centers for Disease Control/Mrs. M. Gatton.)
Silver stain, liver, fatal human leptospirosis. (This image is in the public domain and thus free of any copyright restrictions. Courtesy of the Centers for Disease Control/Dr. Martin Hicklin.)
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.